Skip to main content
A-LevelBiologyInfectious diseases9700/21 · May/June 2024 · Q312 Marks

A class of students was studying the features of some human pathogens. One of the students constructed a flow chart to identify four different human pathogens. The student used information about the structure and mode of transmission of each of these pathogens. Fig. 3.1 shows the partially completed flow chart. [Figure 3.1] Complete the flow chart in Fig. 3.1 by identifying: • the modes of transmission • the scientific names of the pathogens • the name of one of the diseases.

  1. (a)A class of students was studying the features of some human pathogens. One of the students constructed a flow chart to identify four different human pathogens. The student used information about the structure and mode of transmission of each of these pathogens. Fig. 3.1 shows the partially completed flow chart. START pathogen has a cellular structure no pathogen is transmitted in body fluids HIV (HIV/AIDS) yes pathogen is a prokaryote no yes pathogen is transmitted by faecal- oral route pat hogen is transmitted by (malaria) yes pat hogen is transmitted by (tuberculosis) (.........................) Fig. 3.1 Complete the flow chart in Fig. 3.1 by identifying: • the modes of transmission • the scientific names of the pathogens • the name of one of the diseases.[5]
  2. (b)HIV has a nucleic acid core of RNA. The virus also contains the enzyme reverse transcriptase. After HIV enters T-lymphocytes, reverse transcriptase catalyses the formation of DNA using activated DNA nucleotides with the viral RNA as a template. Some drugs, such as tenofovir, have been developed to inhibit the action of reverse transcriptase. The structure of tenofovir is similar to the structure of deoxyribose adenosine monophosphate, as shown in Fig. 3.2. [Figure 3.2] After tenofovir is absorbed into cells it is phosphorylated twice and can be used by reverse transcriptase in the synthesis of DNA. When a tenofovir molecule is added to the DNA strand being synthesised, the process stops. Suggest the mechanism of action of tenofovir to prevent the synthesis of DNA by reverse transcriptase. Use the information in Fig. 3.2 in your answer.[2]
  3. (c)(i)Calculate the percentage of people who received PrEP in 2019 as a percentage of the target set by the UN in 2016. Give your answer to the nearest whole number. %[1]
  4. (c)(ii)PrEP does not prevent transmission of HIV. State and explain how health authorities can reduce the transmission of HIV.[4]

This question uses a diagram from the original paper, which isn't shown here. Open the full paper from the past papers archive to see it.

Mark scheme

Marking points from the official mark scheme (May/June 2024). The mark or mark type is shown in brackets.

  1. [5] (malaria) pathogen is transmitted by: (insect) vector / Anopheles / (a) mosquito;
  2. [5] (malaria) pathogen: Plasmodium, falciparum / ovale / malariae / vivax ; A knowlesi
  3. [5] (tuberculosis) pathogen is transmitted by: airborne droplets / droplet infection / aerosol (infection); I air droplets I water droplets from, coughing / sneezing A alternative transmission only if Mycobacterium bovis stated e.g. (eating) contaminated meat (from infected cattle) (drinking) contaminated milk (drinking) unpasteurised milk from contaminated, cows / cattle
  4. [5] (tuberculosis) pathogen: Mycobacterium, tuberculosis / bovis ;
  5. [5] (faecal-oral route disease): Vibrio cholerae and cholera ; A other pathogens and associated diseases that are transmitted in the same way
  6. [2] any two from:
  7. [2] tenofovir competes with, (activated / phosphorylated) adenine nucleotide / deoxyribose adenosine triphosphate / dATP, for active site / to prevent nucleotides being added to elongating chain ; A (tenofovir acts as a) competitive inhibitor (of reverse transcriptase)
  8. [2] tenofovir forms a phosphodiester bond to elongating DNA strand, but stops further reactions / AW;
  9. [2] tenofovir has, no 3´ -OH so next nucleotide cannot form a phosphodiester bond / no (deoxyribose so cannot form phosphodiester bond ; A pentose R sugar unqualified
  10. [1] 20 (%); R answers with decimal places
  11. [4] there must be at least one statement or at least one explanation to gain max 4, otherwise mark to max 3
  12. [4] any four from:
  13. [4] 1 supply, condoms / femidoms / dental dams / item(s) for protection during sex ;
  14. [4] 2 barrier to transmission during sexual intercourse ;
  15. [4] 3 ref. to, needle exchange schemes / other suitable support for intravenous drug (ab)users ; I clean needles
  16. [4] 4 decreases risk of sharing contaminated equipment / AW ;
  17. [4] 5 use, new needles / new syringes / sterilised equipment / AW, for medical procedures ; I clean needles
  18. [4] 6 decreases risk of transmission from contaminated blood;
  19. [4] 7 provide testing for HIV, in high risk groups / to individuals at high risk ;
  20. [4] 8 for early diagnosis so newly infected people so can start drug treatment immediately;
  21. [4] 8 test pregnant women for HIV / provide powdered milk to women who are HIV positive;
  22. [4] 9 prevent women who are HIV positive passing HIV in breast milk ;
  23. [4] 10 prevent people who are HIV positive being blood donors / screen donated blood / heat-treat donated blood;
  24. [4] 11 prevent receiving blood infected with HIV, during blood transfusions / operations ;
  25. [4] 12 carry out contact tracing;
  26. [4] 13 locate people who, are undiagnosed / may be HIV positive / should be offered test ;
  27. [4] 14 supply (named) drug(s) to people, living with HIV / who are HIV positive / pregnant women with HIV ;
  28. [4] 15 prevents HIV, spreading throughout the body / infecting more T-lymphocytes ; A to reduce viral load
  29. [4] 16 provide, education / information, about, HIV treatments / HIV transmission ;
  30. [4] 17 to raise awareness of ways to reduce infection / AW; A use of barrier methods during sex / safer sex
  31. [4] 18 AVP; e.g. law to make it illegal to knowingly transmit the virus

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Infectious diseases, A-Level Biology (syllabus 9700). Structured question, 12 marks.
Source
A-Level Biology, May/June 2024 Paper 2 Variant 1, question 3.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep